Pediatric acute lymphoblastic leukemia (ALL) is a heterogeneous disease. At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Schrappe, MD, PhD, from University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany, explains that there have been significant advances in the understanding of pediatric ALL subtypes and there is now a need to define the clinical importance of these subtypes.
Get great new content delivered to your inboxSign up
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest Hemonc news and updates